ambroxol has been researched along with Colitis Gravis in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cavalu, S | 1 |
Sharaf, H | 1 |
Saber, S | 1 |
Youssef, ME | 1 |
Abdelhamid, AM | 1 |
Mourad, AAE | 1 |
Ibrahim, S | 1 |
Allam, S | 1 |
Elgharabawy, RM | 1 |
El-Ahwany, E | 1 |
Amin, NA | 1 |
Shata, A | 1 |
Eldegla, M | 1 |
Atef, M | 1 |
Aboraya, M | 1 |
Mohamed, M | 1 |
Anz, N | 1 |
Elmotelb, DA | 1 |
Gabr, F | 1 |
Elzablawy, D | 1 |
Hamada, M | 1 |
Yehia, A | 1 |
Osama, D | 1 |
Mohammed, OA | 1 |
1 other study available for ambroxol and Colitis Gravis
Article | Year |
---|---|
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis.
Topics: Ambroxol; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Colitis, Ulcerative; Colon; Ex | 2022 |